Denali Therapeutics, Inc. (DNLI)
22.16
-0.64
(-2.81%)
USD |
NASDAQ |
Sep 04, 11:31
Denali Therapeutics Cash and Short Term Investments (Annual) : 867.88M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 867.88M |
| December 31, 2024 | 832.33M |
| December 31, 2023 | 1.035B |
| December 31, 2022 | 1.336B |
| December 31, 2021 | 865.41M |
| December 31, 2020 | 1.470B |
| Date | Value |
|---|---|
| December 31, 2019 | 415.36M |
| December 31, 2018 | 464.30M |
| December 31, 2017 | 406.23M |
| December 31, 2016 | 178.33M |
| December 31, 2015 | 30.74M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sangamo Therapeutics, Inc. | 20.95M |
| Sarepta Therapeutics, Inc. | 939.65M |
| Anixa Biosciences, Inc. | 15.17M |